Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TECAR Therapy Might be an Alternative to Dry Needling in the Treatment of Active Myofascial Trigger Points in Upper Trapezius

NCT06273514 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.

NCT NCT06273514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06273514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TECAR Therapy Might be an Alternative to Dry Needling in the Treatment of Active Myofascial Trigger Points in Upper Trapezius
Lead sponsor
Medical University of Silesia
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2020
Completion date
December 31, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pain syndrome of neck, myofascial trigger point pain, myofascial trigger point syndrome